Vanberra Signal

ARIEL Precision Medicine

Curated by Signal

Developer of precision medicine solutions for chronic diseases and cancer

Overview

Ariel Precision Medicine develops solutions for chronic diseases and cancer. Its proprietary SMART-MD database uses systems biology and machine learning to combine symptoms and patient history with advanced genomic data from their NGS tests in order to arrive at an individual patient profile. This profile is then compared against complex databases for disease diagnosis and therapy recommendations. The company hopes to use its platform not only for Mendelian disorders, but also for analyzing complex gene-gene interactions, environmental factors and ancestral data for precision medicine. First application is PancreasDx, aimed at pancreatic diseases.

Key facts

Founded
2013

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of luteinizing hormone monitoring device

    Life Sciences TechnologyTennessee, United States
  • Developer of probiotic supplement for women health

    Life Sciences TechnologyPittston, United States
  • Developing digital cell sorting tools for drug discovery

    Life Sciences TechnologyReno, United States

About ARIEL Precision Medicine

What does ARIEL Precision Medicine do?

Ariel Precision Medicine develops solutions for chronic diseases and cancer.

Where is ARIEL Precision Medicine headquartered?

ARIEL Precision Medicine is headquartered in Pittsburgh, United States.

When was ARIEL Precision Medicine founded?

ARIEL Precision Medicine was founded in 2013.

Which sector is ARIEL Precision Medicine in?

ARIEL Precision Medicine operates in Life Sciences Technology.

Who are ARIEL Precision Medicine's competitors?

Companies similar to ARIEL Precision Medicine include LH surge, Daily Routine, and Bioelectronica.